Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy

(2012) R. Devillier et al.   HAEMATOLOGICA

Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study

(2012) Anas Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

(2012) Anas Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma

(2012) Alison J. Moskowitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy

(2012) Eva Walter et al.   LEUKEMIA & LYMPHOMA

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

(2011) T. A. Fehniger et al.   BLOOD

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

(2011) A. M. Evens et al.   BLOOD

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

(2011) C. H. Moskowitz et al.   BLOOD

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2011) A. Sureda et al.   HAEMATOLOGICA

Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma

(2011) Heidi Mocikova et al.   LEUKEMIA & LYMPHOMA

Bendamustine's Emerging Role in the Management of Lymphoid Malignancies

(2011) Mathias J. Rummel et al.   SEMINARS IN HEMATOLOGY

The Past: What We Have Learned in the Last Decade

(2011) P. Borchmann et al.   Hematology-American Society of Hematology Education Program

Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy

(2009) Luca Castagna et al.   BRITISH JOURNAL OF HAEMATOLOGY

Managing relapsed and refractory Hodgkin lymphoma

(2008) Pauline Brice   BRITISH JOURNAL OF HAEMATOLOGY

Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/Refractory Hodgkin's Lymphoma: Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study Group

(2008) Franck Morschhauser et al.   JOURNAL OF CLINICAL ONCOLOGY